Biomarkers and Personalized Medicine in Cardiovascular Disease Symposium
Parent: School of Medicine
eScholarship stats: Breakdown by Item for June through September, 2026
| Item | Title | Total requests | Download | View-only | %Dnld |
|---|---|---|---|---|---|
| 4h57p2np | A Case of Olanzapine-Induced Dyslipidemia | 209 | 19 | 190 | 9.1% |
| 8jz41307 | Beyond Acute Coronary Syndrome: Troponin Kinetics and Assay Concordance Reveal ICI-Associated Myocarditis | 198 | 22 | 176 | 11.1% |
| 5jn906xz | Comparison of Gen5 and Gen6 high-sensitivity cardiac troponin T in a real-world setting | 195 | 24 | 171 | 12.3% |
| 3jq1r3tr | Nocturnal Respiratory Rate: a Stable, Heritable Trait that Predicts All-Cause Mortality | 175 | 42 | 133 | 24.0% |
| 4330s0ts | Rilonacept Reduces Pericarditis Recurrence Risk, Hospitalizations, and ED visits: Outcomes from the RESONANCE Patient Registry | 146 | 21 | 125 | 14.4% |
| 3sg4f601 | Association of Lipoprotein(a) with ASCVD Risk in Women by Menopausal Status: the UK Biobank | 98 | 13 | 85 | 13.3% |
| 9fz817mq | Early Rise in Urinary TIMP-2 and IGF-BP7 and Prediction of Contrast-Associated Acute Kidney Injury after Invasive Angiography | 94 | 12 | 82 | 12.8% |
| 7dj4w9k5 | Threshold and Kinetic Differences Between Fifth- and Sixth-Generation High-Sensitivity Cardiac Troponin T in Routine Clinical Care Testing | 92 | 30 | 62 | 32.6% |
| 76t7g659 | Association between Triglyceride-Glucose Index and Heart Failure Risk by Body MassIndex in a Multi-Ethnic Cohort | 89 | 28 | 61 | 31.5% |
| 07d513b4 | Serial Lipoprotein(a) Measurements in Heart Transplant Recipients | 88 | 18 | 70 | 20.5% |
| 7tn76435 | Non-Contact Home Bed Sensing for Continuous, Personalized, Automated Detection of Clinical Events | 70 | 30 | 40 | 42.9% |
| 98s6q63w | BNP is Selectively Produced by Amyloid-Associated Cardiomyocytes at Amyloid Border Zones in Patients with Cardiac Amyloidosis | 66 | 37 | 29 | 56.1% |
| 2vq6r0xh | Trends and Disparities in Cardiac Magnetic Resonance Utilization During Index Hospitalization for Myocarditis (2015–2025) | 65 | 21 | 44 | 32.3% |
| 9xn4426d | Lipoprotein(a) and Oxidized Phospholipids in Cardiac Allograft Vasculopathy | 65 | 6 | 59 | 9.2% |
| 7rb8s7p2 | Breast arterial calcification and cardiovascular risk prediction in women with and without standard modifiable risk factors | 62 | 11 | 51 | 17.7% |
| 9w3878bz | Cardiac Testing and Return-to-Exercise Guidance in Non-Fulminant Myocarditis: A Mixed-Methods Study | 62 | 16 | 46 | 25.8% |
| 28h5k7wd | Impact of Polygenic Risk Scoring on Lipid-Lowering Therapy in Primary Prevention for Coronary Artery Disease | 54 | 16 | 38 | 29.6% |
| 4w39n3gt | Management of Uncomplicated Myocarditis in a Young Athlete | 46 | 13 | 33 | 28.3% |
| 5rg6s434 | Evaluating Pediatric High-Sensitivity Troponin Thresholds and Testing Trends: A Multicenter Retrospective Cohort Study | 46 | 9 | 37 | 19.6% |
| 08p535r1 | Contemporary Recurrent Pericarditis Management – Real-World Evidence of Limited Cardiac Magnetic Resonance Imaging Prior to Initiating Rilonacept | 45 | 9 | 36 | 20.0% |
| 8np9m9s2 | Cardiac magnetic resonance imaging paralleled recurrent pericarditis clinical response to rilonacept treatment over 18 months: a RHAPSODY subgroup analysis | 34 | 11 | 23 | 32.4% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.